It has been proposed that LOI of IGF2 is a common feature of cancer stem cells including those in PCa and that LOI enhances stemness, self‐renewal, and resistance against chemo‐ and radiotherapy (Zhao et al., 2016). Here, IGF2 is linked to cancer.